RECENT DEVELOPMENTS IN THE MANAGEMENT OF PARACETAMOL (ACETAMINOPHEN) POISONING

被引：33

作者：

JANES, J ^{[1
]}

ROUTLEDGE, PA ^{[1
]}

机构：

[1] LLANDOUGH HOSP,WELSH NATL POISONS UNIT,PENARTH GP6 1XX,S GLAM,WALES

来源：

DRUG SAFETY | 1992年 / 7卷 / 03期

关键词：

D O I：

10.2165/00002018-199207030-00002

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Paracetamol (acetaminophen) poisoning accounts for almost a third of admissions to our district poisons unit, and is the commonest cause of death in such patients. Antidotal treatment may be effective up to 10h after overdose with oral methionine or up to 24h with acetylcysteine (not 15h as previously suggested for the latter). Patients taking paracetamol overdose while also receiving drugs which induce hepatic enzymes are more susceptible to liver damage, and antidotal treatment may be necessary at lower plasma paracetamol concentrations (50% of the normal treatment line). As survival following liver transplantation is now increasing, it is important to identify early prognostic indicators in fulminant hepatic failure, so that those patients with a high chance of fatal outcome can be considered for transplantation. Useful indicators are the presence of acidosis, marked prolongation of prothrombin time or a continued rise in prothrombin time on day 4 after the overdose. There is no evidence that paracetamol or acetylcysteine are teratogenic in pregnancy. Delays in administering acetylcysteine after paracetamol poisoning in pregnancy have been shown to increase the risk of spontaneous abortion and fetal death, Thus, acetylcysteine should be started as early as possible where treatment is indicated.

引用

页码：170 / 177

页数：8

共 48 条

[21] Meredith T.J., Prescott L.F., Vale J.A., Why do patients still die from paracetamol poisoning?, British Medical Journal, 193, pp. 345-346, (1986)
[22] Miner D.J., Kissinger P.T., Evidence for the involvement of N-acetyl-p-quinoneimine in acetaminophen metabolism, Biochemical Pharmacology, 28, pp. 3285-3290, (1979)
[23] Minton N.A., Henry J.A., Frankel R.J., Fatal paracetamol poisoning in an epileptic, Human Toxicology, 7, pp. 33-34, (1988)
[24] Mitchell J.R., Jollow D.J., Potter W.Z., Gillette J.R., Brodie B.B., Acetaminophen-induced hepatic necrosis: IV. Protective role of glutathione, Journal of Pharmacology and Experimental Therapeutics, 187, pp. 211-217, (1973)
[25] Mitchell J.R., Thorgeirsson S.S., Potter W.Z., Jollow D.J., Reiser H., Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy, Clinical Pharmacology and Therapeutics, 16, pp. 676-684, (1974)
[26] Moore M., Thor H., Moore G., Nelson S., Moldeus P., Orrenius S., The toxicity of acetaminophen and N-acetyl-p-benzopquinone-imine (NABQI) in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca<sup>++</sup>, Journal of Biological Chemistry, 260, pp. 13035-13040, (1985)
[27] Mortality statistics — accidents and violence, (1989)
[28] O'Grady J.G., Alexander G.J.M., Hayllar K.M., Willia R., Early indicators of prognosis in fulminant hepatic failure, Gastroenterology, 97, pp. 439-445, (1989)
[29] O'Grady J.G., Gion A.E.S., O'Brien C.J., Pucknell A., Hughes R.D., Et al., Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure, Gastroenterology, 94, pp. 1186-1192, (1988)
[30] Parker D., White J.P., Paton D., Routledge P.A., Safety of late acetylcysteine treatment in paracetamol poisoning, Human and Experimental Toxicology, 9, pp. 25-27, (1990)

← 1 2 3 4 5 →